ArticleArthritis & rheumatology (Hoboken, N.J.)2020

Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study).

Stanley Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.